ArticleJournal of the National Cancer Institute2008
Screening for cervical cancer in the era of the HPV vaccine--the urgent need for both new screening guidelines and new biomarkers.
Article in Journal of the National Cancer Institute, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- MicroRNA-Based Triage of HPV-Positive Women Using Liquid-Based Cytology: Diagnostic Performance and Network-Level Insights.Cancers · 2026Article
- Performance of an ancillary test for cervical cancer that measures miRNAs and cytokines in serum and cervical mucus.Cancer science · 2024Article
- Nomogram for predicted probability of cervical cancer and its precursor lesions using miRNA in cervical mucus, HPV genotype and age.Scientific reports · 2022Article
- Identification of miRNAs in cervical mucus as a novel diagnostic marker for cervical neoplasia.Scientific reports · 2018Article
- Clinical Utility of Molecular Biomarkers in Cervical Squamous Intraepithelial Lesions in a Young Adult Population.Journal of lower genital tract disease · 2016Article
- Optimizing technology for cervical cancer screening in high-resource settings.Expert review of obstetrics & gynecology · 2011Article
- Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer.Molecular cancer · 2010Article
- The impact of human papillomavirus vaccination on cervical cancer prevention efforts.Gynecologic oncology · 2009Review
- Distinct human papillomavirus type 16 methylomes in cervical cells at different stages of premalignancy.Virology · 2009Article
- Development and evaluation of a liquid bead microarray assay for genotyping genital human papillomaviruses.Journal of clinical microbiology · 2009Article
- New paradigms in cervical cancer prevention: opportunities and risks.BMC women's health · 2008Review
- Human papillomavirus-related gynecologic neoplasms: screening and prevention.Reviews in obstetrics & gynecology · 2008Article
Corrections and comments
- Comment on
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
18314471What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.